Search results :

Lisdexamfetamine dimesylate

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Decreased appetite 27% - 39% 2% - 4% x x x x x
Malnutrition 27% 3% x x
Insomnia postmarketing, 13% - 27% 3% - 8% x x x x x
Mental disorder postmarketing, 3% - 27% 0% - 8% x x x
Gastrointestinal disorder 4% - 26% 1% - 6% x x x x
Abdominal pain upper 12% 6% x x x x x
Irritability 10% 0% x x x x x
Vomiting 9% 4% x x x x x
Weight decreased 3% - 9% 0% - 1% x x x x x
Nausea 6% - 7% 0% - 3% x x x x x
Anxiety 6% 0% x x x
Anorexia 5% 0% x x x
Dry mouth 4% - 26% 0% - 3% x x x x x
Feeling jittery 4% 0% x x x
Diarrhoea postmarketing, 7% 0% x x x x x
Hyperhidrosis 3% 0% x x x
Agitation postmarketing, 3% 0% x x x x x
Unspecified disorder of skin and subcutaneous tissue 3% 0% x x x
Affect lability 3% 0% x x x x x
Blood pressure increased 3% 0% x x x
Dizziness postmarketing, 5% 0% x x x x x
Dyspnoea 2% 0% x x x
Body temperature increased 2% 1% x x x x x
Mediastinal disorder 2% 0% x x
Nervous system disorder postmarketing, 2% - 5% 0% x x x x
Rash postmarketing, 3% 0% x x x x x
Tachycardia postmarketing, 2% 0% x x x x x
Tremor postmarketing, 2% 0% x x x x x
Somnolence postmarketing, 2% 1% x x x x x
Aggression postmarketing x x
Anaphylactic shock postmarketing x x x x x
Angioedema postmarketing x x x x x
Bruxism postmarketing x
Constipation postmarketing x x x x
Sudden death postmarketing x x x
Depression postmarketing x
Diplopia postmarketing x x x
Dyskinesia postmarketing x x x x x
Toxic epidermal necrolysis postmarketing x x x
Eye disorder postmarketing x x
Fatigue postmarketing x
Hallucination postmarketing x
Headache postmarketing x x x x x
Cardiac disorder postmarketing x x
Hepatitis postmarketing x x x
Hypersensitivity postmarketing x x x x x
Immune system disorder postmarketing x x
Mydriasis postmarketing x x x
Myocardial infarction postmarketing x x x
Palpitations postmarketing x x x x x
Convulsion postmarketing x x x x x
Stevens-Johnson syndrome postmarketing x x x x x
Cerebrovascular accident postmarketing x x x
Tourette's disorder postmarketing x x x
Urticaria postmarketing x x x x x
Digestion impaired postmarketing x
Dysphoria postmarketing x x x x
Euphoric mood postmarketing x x x x
Erectile dysfunction postmarketing x x x x x
Hepatobiliary disease postmarketing x x
Psychotic episode postmarketing x x x
Mania postmarketing x
Vision blurred postmarketing x x
Cardiomyopathy postmarketing x x x x x
Dermatillomania postmarketing x x x
Logorrhoea postmarketing x x
Libido decreased x x x
Hypertension x x x
Weight increased x x x
Ventricular hypertrophy x x x x x
Initial insomnia x x x x
Middle insomnia x x
Visual disturbance x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LISDEXAMFETAMINE DIMESYLATE / VYVANSE

Side effects:42
Source:FDA

LISDEXAMFETAMINE DIMESYLATE / VYVANSE

Side effects:42
Source:FDA

LISDEXAMFETAMINE

Side effects:46
Source:FDA Structured Product Label

LISDEXAMFETAMINE

Side effects:59
Source:FDA Structured Product Label

LISDEXAMFETAMINE

Side effects:70
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label